Robustness of quantitative hypoxia PET image analysis for predicting local tumor control

References

• Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol 2012;9:674–87.
   PubMed Web of Science ®Google Scholar
• Kikuchi M, Yamane T, Shinohara S, Fujiwara K, Hori S, Tona Y, et al. 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma. Ann Nucl Med 2011;25: 625–33.
   PubMed Web of Science ®Google Scholar
• Rajendran JG, Schwartz DL, O’Sullivan J, Peterson LM, Ng P, Scharnhorst J, et al. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 2006;12: 5435–41.
   PubMed Web of Science ®Google Scholar
• Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S. Dose painting in radiotherapy for head and neck squamous cell carcinoma: Value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 2009;50:1020–7.
   PubMed Web of Science ®Google Scholar
• Zips D, Zöphel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, et al. Exploratory prospective trial of hypoxia- specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol 2012;105:21–8.
   PubMed Web of Science ®Google Scholar
• Mortensen LS, Johansen J, Kallehauge J, Primdahl H, Busk M, Lassen P, et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial. Radiother Oncol 2012;105:14–20.
   PubMed Web of Science ®Google Scholar
• Souvatzoglou M, Grosu AL, Röper B, Krause BJ, Beck R, Reischl G, et al. Tumour hypoxia imaging with 18F-FAZA PET in head and neck cancer patients: A pilot study. Eur J Nucl Med Mol Imaging 2007;34:1566–75.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: A planning study. Int J Radiat Oncol Biol Phys 2007;68:291–300.
   PubMed Web of Science ®Google Scholar
• Hoeben BAW, Bussink J, Troost EGC, Oyen WJG, Kaanders JHAM. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 2013;52:1257–71.
   PubMed Web of Science ®Google Scholar
• Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50:11S–20S.
   PubMed Web of Science ®Google Scholar
• Boellaard R, Oyen WG, Hoekstra C, Hoekstra O, Visser E, Willemsen A, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008; 35:2320–33.
   PubMed Web of Science ®Google Scholar
• Boellaard R, Hristova I, Ettinger S, Sera T, Stroobants S, Chiti A, et al. EARL FDG-PET/CT accreditation program: Feasibility, overview and results of first 55 successfully accredited sites. J Nucl Med 2013;54:2052.
   Google Scholar
• Kikuchi M, Koyasu S, Shinohara S, Usami Y, Imai Y, Hino M, et al. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Head Neck Epub 2014 Jul 21.
   Web of Science ®Google Scholar
• Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. Variability in PET quantitation within a multicenter consortium. Med Phys 2010;37:3660–6.
   PubMed Web of Science ®Google Scholar
• Sattler B, Lee JA, Lonsdale M, Coche E. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol 2010; 96:288–97.
   PubMed Web of Science ®Google Scholar
• Håkansson K, Specht L, Aznar MC, Rasmussen JH, Bentzen SM, Vogelius IR. Prescribing and evaluating target dose in dose-painting treatment plans. Acta Oncol 2014;53:1251–6.
   PubMed Web of Science ®Google Scholar
• Bittner M-I, Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA, et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol 2013;108:511–6.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, et al. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med 2013;54:201–7.
   PubMed Web of Science ®Google Scholar
• Bollineni VR, Koole MJB, Pruim J, Brouwer CL, Wiegman EM, Groen HJM, et al. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: Possible implications for radiotherapy treatment planning strategies. Radiother Oncol 2014;113:198–203.
   PubMed Web of Science ®Google Scholar